Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers-Reference-Cited by-同舟云学术

Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers

Published:2017-07-12 Issue:398 Volume:9 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Kim Jungsun¹^ORCID,Bamlet William R.²,Oberg Ann L.²^ORCID,Chaffee Kari G.²^ORCID,Donahue Greg¹,Cao Xing-Jun³^ORCID,Chari Suresh⁴,Garcia Benjamin A.³,Petersen Gloria M.⁵,Zaret Kenneth S.¹^ORCID

Affiliation:

1. Institute for Regenerative Medicine, Department of Cell and Developmental Biology, Abramson Cancer Center (Tumor Biology Program), Perelman School of Medicine, University of Pennsylvania, 9-131 Smilow Center for Translational Research, 3400 Civic Center Boulevard, Philadelphia, PA 19104–5157, USA.

2. Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.

3. Epigenetics Program, Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

4. Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.

5. Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.

Abstract

THBS2 and CA19-9 markers in human blood improve detection of pancreatic ductal adenocarcinoma.

Funder

U.S. Department of Defense

NIH Office of the Director

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference56 articles.

1. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

2. Early Detection of Sporadic Pancreatic Cancer

3. A clinical evaluation of carbohydrate antigen 19-9 and carcinoembryonic antigen in patients with pancreatic carcinoma

4. Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular pathology and protein markers for pancreatic cancer: relevance in staging, in adjuvant therapy, in determination of minimal residual disease, and follow-up;Hepatobiliary Surgery and Nutrition;2024-02

2. Determining the feasibility of calculating pancreatic cancer risk scores for people with new-onset diabetes in primary care (DEFEND PRIME): study protocol;BMJ Open;2024-01

3. Cell-Surface Glycan Labeling and Sensing;Targets;2023-12-31

4. A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma;Cells;2023-12-19

5. Managing complications of chronic pancreatitis: a guide for the gastroenterologist;Expert Review of Gastroenterology & Hepatology;2023-12-02